TWST Form 144: Insider Sold 7,470 Shares; 206-Share Sale Proposed

TWST Form 144 summary: This notice reports proposed and recent sales of Twist Bioscience common stock by an individual identified as Patrick Finn.

Rhea-AI Filing Summary

TWST Form 144 summary: This notice reports proposed and recent sales of Twist Bioscience common stock by an individual identified as Patrick Finn. The filer proposes to sell 206 shares via Fidelity Brokerage with an aggregate market value of $6,007.15 and lists the company's outstanding share count as 60,360,925. The 206 shares were acquired on 10/01/2025 through restricted stock vesting and payment is listed as compensation. The filing also discloses four reported sales in the prior three months totaling 7,470 shares for $225,564.62. The signer represents they have no undisclosed material information about the issuer.

Positive

• None.

Negative

• Insider sold 7,470 shares in the past three months for $225,564.62
• Proposed sale of 206 shares (aggregate market value $6,007.15) to be executed on 10/02/2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the seller named in the TWST Form 144?

The filing lists Patrick Finn as the person for whose account the securities were or will be sold.

How many shares does the Form 144 propose to sell for TWST?

The notice proposes the sale of 206 shares of common stock with an aggregate market value of $6,007.15.

What recent insider sales are disclosed in this TWST filing?

Four sales in the prior three months totaling 7,470 shares for $225,564.62 (dates: 07/02/2025, 07/23/2025, 08/04/2025, 08/21/2025).

How were the 206 shares being offered for sale acquired?

They were acquired on 10/01/2025 via restricted stock vesting, with consideration listed as compensation.

What outstanding share count does the filing report for TWST?

The filing lists 60,360,925 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 03:35 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001755970
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Twist Bioscience Corp
SEC File Number	001-38720
Address of Issuer	681 GATEWAY BLVD. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	800-719-0671
Name of Person for Whose Account the Securities are To Be Sold	Finn Patrick John
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	206	6007.15	60360925	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Vesting	Issuer			206	10/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	07/02/2025	209	7564.36
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	07/23/2025	2232	79773.02
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	08/04/2025	3189	90453.11
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	08/21/2025	1840	47774.13

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	10/02/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tyler Johnson, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Patrick Finn
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)